Evaluation of the practical applications of fluorescence in situ hybridization in the prenatal diagnosis of positive noninvasive prenatal screenings
- 21 July 2021
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 7422-7429
Abstract
To investigate the application value and limitations of fluorescence in situ hybridization (FISH) in prenatal diagnosis of positive results for trisomies 13, 18, 21 (T13, T18, T21) and sex chromoso...Keywords
Funding Information
- Guangzhou Municipal Science and Technology Program key projects (18ZXDBSY00190)
- National Natural Science Foundation of China (#81901502)
- National Natural Science Foundation of China (#81971416)
- TMUGH Incubation Foundation (ZYYFY2017025)
This publication has 17 references indexed in Scilit:
- Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2016
- Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysisBMJ Open, 2016
- Interphase fluorescence in situ hybridization assisting in prenatal counseling for amniocentesis karyotyping-detected fetal mosaicismTaiwanese Journal of Obstetrics and Gynecology, 2015
- Committee Opinion No. 640Obstetrics & Gynecology, 2015
- Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal DiagnosisPrenatal Diagnosis, 2015
- Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnanciesUltrasound in Obstetrics & Gynecology, 2015
- Optimized criteria for using fluorescence in situ hybridization in the prenatal diagnosis of common aneuploidiesPrenatal Diagnosis, 2008
- Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessmentThe Lancet, 2005
- Residual risk for cytogenetic abnormalities after prenatal diagnosis by interphase fluorescence in situ hybridization (FISH)Prenatal Diagnosis, 2003
- Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): 2‐year multi‐center retrospective study and review of the literaturePrenatal Diagnosis, 2001